Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients With Moderate-to-Severe Psoriasis. J of Skin 2018, 2 (S1), S1. https://doi.org/10.25251/skin.2.supp.1.